QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.061986v1 309/2/804    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yip, L. Articles by Kwok, Y. N. Search for Related Content PubMed PubMed Citation Articles by Yip, L. Articles by Kwok, Y. N. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide UniGene Compound via MeSH Substance via MeSH

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Role of Adenosine A_2A Receptor in the Regulation of Gastric Somatostatin Release

Department of Physiology, University of British Columbia, Vancouver, British Columbia, Canada

Adenosine has been demonstrated to inhibit gastric acid secretion. In the rat stomach, this inhibitory effect may be mediated indirectly by increasing the release of somatostatin-like immunoreactivity (SLI). Results show that adenosine analogs augmented SLI release in the isolated vascularly perfused rat stomach. The rank order of potency of the analogs in stimulating SLI release was 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680) 5'-N-ethylcarboxamidoadenosine > 2-chloroadenosine > R-(-)-N⁶-(2-phenylisopropyl)adenosine >1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl--D-ribofuranuronamide > N⁶-cyclopentyladenosine N⁶-cyclohexyladenosine > S-(+)-N⁶-(2-phenylisopropyl) adenosine, suggesting the involvement of the A_2A receptor. In agreement, 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a] [1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385), an A_2A receptor antagonist, was shown to abolish the adenosine- and CGS 21680-stimulated SLI release. Immunohistochemical studies reveal the presence of A_2A receptor immunoreactivity on the gastric plexi and mucosal D-cells, but not on parietal cells and G-cells, suggesting that adenosine may act directly on D-cells or indirectly on the gastric plexi to augment SLI release. The present study also demonstrates that the structure of the mucosal A_2A receptor is identical to that in the rat brain, and that alternative splicing of this gene does not occur. A real-time reverse transcription-polymerase chain reaction assay has also been established to quantify the levels of A_2A receptor mRNA. Results show that gastric tissues contained significantly lower levels of A_2A receptor mRNA compared with the striatum. The lowest level was detected in the mucosa. In conclusion, adenosine may act on A_2A receptors to augment SLI release and consequently control gastric acid secretion.

Address correspondence to: Dr. Yin Nam Kwok, Department of Physiology, University of British Columbia, 2146 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3. E-mail: kynkwok{at}interchange.ubc.ca

This article has been cited by other articles:

				L. Yip, H. C. H. Leung, and Y. N. Kwok Effect of Omeprazole on Gastric Adenosine A1 and A2A Receptor Gene Expression and Function J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 180 - 189. [Abstract] [Full Text] [PDF]

				L. Yip, H. C. H. Leung, and Y. N. Kwok Role of Adenosine A1 Receptor in the Regulation of Gastrin Release J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 477 - 487. [Abstract] [Full Text] [PDF]